{"id":62566,"date":"2026-01-30T01:06:00","date_gmt":"2026-01-30T00:06:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/"},"modified":"2026-01-30T01:06:00","modified_gmt":"2026-01-30T00:06:00","slug":"giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/","title":{"rendered":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility"},"content":{"rendered":"
\n

LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine\u00ae<\/sup>, Gilad&Gilad<\/a> is excited to announce the launch of AgmaVet\u00ae<\/sup> For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nOsteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. It affects some 30-50% of dogs, cats and horses. In horses, its annual impact is as high as $1 billion.<\/p>\n

\nScientific evidence indicates that improper nerve functions underlie the tremendous discomfort caused by deteriorating OA health. This explains why existing treatments to maintain joint health <\/strong>are of limited effect and yield inconsistent results. \u201cThere is a clear unmet need for safe and effective natural dietary products <\/strong>that can relieve <\/strong>aches and leg weakness by promoting both resilient nerve functions and proper joints mobility,” said Dr. Gad M. Gilad, CEO of Gilad&Gilad.<\/p>\n

\nGilad&Gilad developed AgmaVet\u00ae<\/sup> For Horses based on substantial scientific research and clinical trials. A recently published clinical trial has demonstrated that G-Agmatine\u00ae <\/sup>can improve OA-associated lameness as well as protect horses from developing gastric ulcers, a serious side effect of existing treatments (J. Clin. Med. <\/a><\/i>2022<\/b>, 11(24), 7283<\/a>).<\/p>\n

\nAgmaVet\u00ae<\/sup> For Horses together with AgmaVet\u00ae<\/sup><\/a> <\/sup>(for small animals) and AgmaSet\u00ae<\/sup><\/a> belong to the Agmaceuticals\u00ae<\/sup> line of patent protected products containing the neuroprotective ingredient G-Agmatine\u00ae<\/sup>. These category-leading products are superior to existing therapies for sustaining resilient nerve functions and proper joints mobility.<\/p>\n

\nYou are Invited to upcoming showcases of AgmaVet\u00ae<\/sup> For Horses:
\n
<\/b>– WVC Conference (February 16-18, 2026, in Las Vegas) \u2013 Booth #821
\n
<\/b>– Natural Product Expo West (March 16-18, 2026, in Anaheim) \u2013 Booth #3673<\/b><\/p>\n

\nAbout <\/b>Gilad&Gilad<\/b><\/a><\/p>\n

\nGilad&Gilad is a health science company with core competencies in Neuroscience, largely invested in R & D. The Company developed the exclusive Agmaceuticals\u00ae<\/sup> product line based on its founders\u2019 discovery of the neuroprotective properties of the natural molecule Agmatine. G-Agmatine\u00ae<\/sup> is the best brand of premium grade agmatine. Agmatine usage for supporting nerve health and joint mobility is patented (US patents: 8,916,612; 9,585,852; 11,622,949; 11,877,990).<\/p>\n

\n\u2013 For further information visit: https:\/\/ForNerveHealth.com<\/a>, where you can download copies of relevant publications and a slide presentation.<\/p>\n

\n\u2013 The Company seeks investments, distributors, and is open to acquisition or licensing inquiries.<\/p>\n

Contacts<\/b> <\/p>\n

\nGad M. Gilad, Ph.D.
\n
Research, Gilad&Gilad LLC<\/i><\/b>
1-702-233-5553
\n
info@ForNerveHealth.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine\u00ae, Gilad&Gilad is excited to announce the launch of AgmaVet\u00ae For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort. Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62566","6":"format-standard","7":"category-industry"},"yoast_head":"\nGilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine\u00ae, Gilad&Gilad is excited to announce the launch of AgmaVet\u00ae For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort. Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-30T00:06:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility\",\"datePublished\":\"2026-01-30T00:06:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/\"},\"wordCount\":400,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122904271\\\/en\\\/2697786\\\/22\\\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/\",\"name\":\"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122904271\\\/en\\\/2697786\\\/22\\\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg\",\"datePublished\":\"2026-01-30T00:06:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122904271\\\/en\\\/2697786\\\/22\\\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122904271\\\/en\\\/2697786\\\/22\\\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/","og_locale":"en_US","og_type":"article","og_title":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend","og_description":"LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine\u00ae, Gilad&Gilad is excited to announce the launch of AgmaVet\u00ae For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort. Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-30T00:06:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility","datePublished":"2026-01-30T00:06:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/"},"wordCount":400,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/","url":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/","name":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg","datePublished":"2026-01-30T00:06:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260122904271\/en\/2697786\/22\/agmavet_%2B_agmaset_bottles_v3-1_%2810-2025%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/giladgilad-launches-agmavet-for-horses-for-promoting-resilient-nerve-functions-and-joints-mobility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilad&Gilad Launches AgmaVet\u00ae For Horses for Promoting Resilient Nerve Functions and Joints Mobility"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62566"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62566\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}